| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $59.2M | 0.08% | 2.85M | −6.7% | Q2 2026 |
| Fundsmith · Terry Smith | $13.5M | 0.10% | 653.32K | −5.6% | Q2 2026 |
| Bridgewater Associates · Ray Dalio | $2.7M | 0.01% | 131.45K | +9.5% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Jonathan Jackson IL01 | 1 | 1 | +$0 | Sold Nov 6, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Nov 6, 25 | Jonathan Jackson IL01 | Joint | Sell | $15,001 - $50,000 | Dec 5, 25 (29d) | |
| Aug 25, 25 | Jonathan Jackson IL01 | Joint | Buy | $15,001 - $50,000 | Sep 23, 25 (29d) |
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Wampler Kira SchererDirector | Sale at price 28.91 per share. | 2K | $57.82K |
| Sep 30, 2026 | Wampler Kira SchererDirector | — | 2K | — |
| Sep 23, 2026 | Zatz Steven L. M.D.President | Stock Award(Grant) at price 0.00 per share. | 152.4K | — |
| Sep 14, 2026 | Sitaram SiddharthOfficer | Sale at price 26.02 per share. | 2.1K | $54.04K |
| Sep 14, 2026 | Sitaram SiddharthOfficer | — | 5K | — |
| Aug 31, 2026 | Wampler Kira SchererDirector | Sale at price 26.33 per share. | 2K | $52.66K |
| Aug 31, 2026 | Wampler Kira SchererDirector | — | 2K | — |
| Aug 26, 2026 | Cabral Timothy SDirector | Stock Award(Grant) at price 0.00 per share. | 8.1K | — |
| Aug 26, 2026 | Spain KevinDirector | Stock Award(Grant) at price 0.00 per share. | 8.1K | — |
| Aug 26, 2026 | Benjamin Regina M.Director | Stock Award(Grant) at price 0.00 per share. | 8.1K | — |
| Aug 26, 2026 | Wampler Kira SchererDirector | Stock Award(Grant) at price 0.00 per share. | 8.1K | — |
| Aug 26, 2026 | Yang Watkin Phoebe LDirector | Stock Award(Grant) at price 0.00 per share. | 8.1K | — |
| Aug 24, 2026 | Wampler Kira SchererDirector | Sale at price 24.95 per share. | 2K | $49.90K |
| Aug 24, 2026 | Wampler Kira SchererDirector | — | 2K | — |
| Aug 12, 2026 | Sitaram SiddharthOfficer | Sale at price 24.94 per share. | 1.8K | $44.14K |
| Aug 12, 2026 | Sitaram SiddharthOfficer | — | 5K | — |
| Aug 6, 2026 | Cabral Timothy SDirector | Sale at price 27.40 per share. | 7.5K | $205.50K |
| Aug 6, 2026 | Cabral Timothy SDirector | — | 7.5K | — |
| Jul 14, 2026 | Sitaram SiddharthOfficer | Sale at price 22.02 per share. | 1.7K | $38.14K |
| Jul 14, 2026 | Sitaram SiddharthOfficer | — | 4.8K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.4 | -34.5 | -5.0 | 4.9 | -12.4 | -3.1 | 0.8 | 27.7 | 6.1 | 7.9 | −30.9% | ||
| 2025 | 10.7 | 19.3 | -17.7 | -2.0 | -8.4 | 17.8 | -4.2 | 15.6 | 7.7 | -9.8 | -22.1 | -13.9 | −17.1% |
| 2024 | -3.9 | 4.7 | -4.7 | -9.7 | 14.2 | 0.9 | 0.1 | 31.4 | 18.5 | -4.2 | 27.0 | 0.7 | +90.4% |
| 2023 | 5.1 | -4.6 | -3.7 | 13.5 | -16.5 | 10.9 | 5.0 | -33.3 | -11.0 | -3.7 | 13.8 | 20.6 | −16.4% |
| 2022 | -9.1 | 34.6 | -15.1 | -23.5 | -12.2 | -0.5 | 21.5 | -21.6 | -8.9 | -12.4 | 28.4 | -1.3 | −33.1% |
| 2021 | 6.4 | 48.6 | -12.3 | -13.9 | -2.6 | -25.9 | −13.9% |
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Buy / hold / sell counts